Theriva Biologics's market cap is currently $3.31M. The company's EPS TTM is $-1.93; its P/E ratio is -0.03; Theriva Biologics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
